Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fundación Para La Investigación Del Hospital Clínico De La Comunidad Valenciana currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner and is located within 1 distinct art unit. This structure indicates a very specific technical focus for the company's current patent filings. The 1 pending office action is the only matter currently active in the company's portfolio.
The busiest examiner for this portfolio is IVANOVA, SVETLANA M, who is handling 1 pending office action. Since the total number of pending office actions is 1, this examiner is the sole official reviewing the company's current applications. The 1 distinct examiner and 1 distinct art unit provide a centralized point of contact for the company's intellectual property matters.
With 1 distinct examiner and 1 distinct art unit, the prosecution process is highly focused. This allows for a direct relationship with the examiner in the Biotechnology & Pharmaceuticals field. Practitioners should note that the 1 pending office action represents the full extent of the current interaction with the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IVANOVA, SVETLANA M | 1 | 50.9% | +51.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18695991 | HALOPERIDOL FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY | IVANOVA, SVETLANA M | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18695991 | HALOPERIDOL FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY | IVANOVA, SVETLANA M | 1627 | §103 | Final Rejection | — | Pending | Mar 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFundación Para La Investigación Del Hospital Clínico De La Comunidad Valenciana has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Svetlana M Ivanova has the most, with 1 of Fundación Para La Investigación Del Hospital Clínico De La Comunidad Valenciana's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
